financetom
Business
financetom
/
Business
/
Cheniere Energy to Proceed With Corpus Christi Debottlenecking Project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cheniere Energy to Proceed With Corpus Christi Debottlenecking Project
Jun 24, 2025 5:35 AM

08:08 AM EDT, 06/24/2025 (MT Newswires) -- Cheniere Energy (LNG) said Tuesday that its board has decided to proceed with the Corpus Christi midscale trains 8 and 9 debottlenecking project.

The company said it has notified its engineering, procurement, and construction partner Bechtel Energy to proceed with the project's construction. It will be adjacent to the Corpus Christi Stage 3 project and include two midscale trains and other debottlenecking infrastructure, said Cheniere Energy.

According to the company, the two trains are expected to have a total capacity of more than 3 million tonnes per annum of liquefied natural gas.

Cheniere Energy said it estimates an over 10% increase in the total run-rate liquefaction capacity at its Sabine Pass and Corpus Christi terminals from the two new trains, the Corpus Christi Stage 3 project, and other identified debottlenecking opportunities across the platform.

In addition, the company said it plans to increase its dividend to $2.22 per share from $2.00 per share on an annualized basis in Q3.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FTC Seeking Info From JPMorgan, Mastercard on 'Surveillance Pricing'
FTC Seeking Info From JPMorgan, Mastercard on 'Surveillance Pricing'
Jul 23, 2024
09:48 AM EDT, 07/23/2024 (MT Newswires) -- The US Federal Trade Commission said Tuesday it issued orders to JPMorgan Chase ( JPM ) , Mastercard ( MA ) , Accenture ( ACN ) and five other companies that offer surveillance pricing products and services that incorporate data about consumers' characteristics and behavior. The orders seek information about the potential impact...
Enlivex Therapeutics Gets Regulatory Nod in Israel to Begin Phase I Trial for Potential Psoriatic Arthritis Treatment
Enlivex Therapeutics Gets Regulatory Nod in Israel to Begin Phase I Trial for Potential Psoriatic Arthritis Treatment
Jul 23, 2024
09:53 AM EDT, 07/23/2024 (MT Newswires) -- Enlivex Therapeutics ( ENLV ) said Tuesday it has received authorization from the Israeli Ministry of Health to start a phase I clinical trial to assess the safety and tolerability of Allocetra after injection into an affected joint in psoriatic arthritis patients. The company said measuring the frequency and severity of adverse events...
US, Canadian pot firms eye Germany for growth as market stagnates at home
US, Canadian pot firms eye Germany for growth as market stagnates at home
Jul 23, 2024
By Sourasis Bose (Reuters) - North American cannabis firms, facing prohibitive laws, an overcrowded market and a deeply entrenched illicit sector at home are ramping up investments in Germany after the country partly legalized marijuana use. Germany, the largest medical cannabis market in Europe, decriminalized cannabis possession and small-scale home cultivation in April, making it easier for doctors to prescribe...
Arcutis Biotherapeutics Submits Supplemental New Drug Application to US FDA for Psoriasis Treatment
Arcutis Biotherapeutics Submits Supplemental New Drug Application to US FDA for Psoriasis Treatment
Jul 23, 2024
09:48 AM EDT, 07/23/2024 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) said Tuesday that it has submitted a supplemental new drug application to the US Food and Drug Administration for Zoryve foam 0.3% to treat adults and adolescents aged 12 and above with scalp and body psoriasis. The submission is backed by positive results from a late-stage trial, a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved